Vildaways

Vildagliptin

• Vildagliptin add on therapy in patient with metformin
• Reduces festive BG
• Reduces Postprandial BG & Glucogen.
• No change to 24-hour insulin secretor(U.Cln bnaicrinol Metad 2UU4:89:40/8.84)
• Reduces HB1 by 0.6-1.1%
• Rapidly absorbed & high bio availability (85%) offer on oral administration
• Efficacious, weight neutral with low risk of hyperglycemia as monotherapy

Metformin

• Metformin is a Biguanide, lowers blood glucose by increasing the sensitivity of liver, muscle, Fat and other peripheral tissues for uptake of glucose and also enhances effect of insulin.
• Metformin reduces the complications of diabetes such as heart disease, retinal damage and kidney disease.
• Reduces chances of Polyhydra & Polyurea.
• Type-II diabetes.

“Best Choice for the Diabetic Patients…”